Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ellagic Acid Alleviates Colitis by Inhibiting Ferroptosis via Nrf2/GPX4 Signaling

ABSTRACT:

Ferroptosis, an iron-dependent form of regulated cell death, has emerged as a key driver of intestinal epithelial injury in inflammatory bowel disease (IBD). The Nrf2–GPX4 signaling axis provides a critical defense against ferroptotic damage; however, its therapeutic modulation remains underexplored. Here, we report that ellagic acid (EA), a natural dietary polyphenol, attenuates dextran sulfate sodium (DSS)-induced colitis by suppressing ferroptosis through activation of the Nrf2/GPX4 pathway. EA treatment markedly reduced disease severity, preserved intestinal barrier integrity, and limited immune cell infiltration. Mechanistically, EA restored GPX4 and SLC7A11 expression while decreasing ACSL4 expression and lipid peroxidation in colonic epithelial (Caco-2) and macrophage (RAW264.7) cells. These findings identify EA as a potent ferroptosis inhibitor that acts on both epithelial and immune compartments, underscoring its potential as a natural therapeutic agent for the prevention and treatment of IBD.

INSTRUMENT(S): Liquid Chromatography MS - negative - reverse-phase, Liquid Chromatography MS - positive - reverse-phase

PROVIDER: MTBLS13535 | MetaboLights | 2025-12-19

REPOSITORIES: MetaboLights

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	a_MTBLS13535_LC-MS_negative_reverse-phase_metabolite_profiling.txt	Txt
	a_MTBLS13535_LC-MS_positive_reverse-phase_metabolite_profiling.txt	Txt
	i_Investigation.txt	Txt
	m_MTBLS13535_LC-MS_negative_reverse-phase_metabolite_profiling_v2_maf.tsv	Tabular
	m_MTBLS13535_LC-MS_positive_reverse-phase_metabolite_profiling_v2_maf.tsv	Tabular

Items per page:

1 - 5 of 6

Similar Datasets

Bulk transcriptomic profiling reveal the epithelial-protective role of ITGBL1 during the progression of colitis

Project description:Inflammatory bowel disease (IBD) is characterized by progressive epithelial injury, chronic inflammation, and impaired intestinal barrier function. To comprehensively delineate the epithelial alterations and stress-related responses that occur during colitis progression, we investigated the functional role of integrin beta-like 1 (ITGBL1) in intestinal epithelial cells (IECs). Using patient specimens and DSS-induced colitis models, we identified marked upregulation of ITGBL1 in inflamed intestinal tissues. Loss of ITGBL1 resulted in the emergence of ferroptosis-prone epithelial subsets exhibiting elevated ACSL4 expression, lipid peroxidation, mitochondrial shrinkage, and enhanced oxidative stress, all of which were associated with aggravated epithelial damage and worse inflammatory outcomes. We further demonstrated that ITGBL1 deficiency activated the ANGPT2/PI3K-AKT signaling axis in IECs, leading to exaggerated oxidative stress and ferroptosis, accompanied by reduced expression of key tight-junction proteins including E-cadherin, ZO-1, occludin, and claudin-1. These alterations impaired epithelial cohesion and barrier integrity during disease progression. In contrast, supplementation with recombinant ITGBL1 suppressed ANGPT2 expression, mitigated PI3K-AKT hyperactivation, restored mitochondrial structure, alleviated ferroptosis, and improved epithelial barrier function. In conclusion, ITGBL1 serves as a critical regulator of epithelial stress responses and barrier stability during colitis, acting by restraining ANGPT2-mediated PI3K-AKT activation and ferroptotic cell death. These findings highlight a previously unrecognized epithelial-protective mechanism and identify the ITGBL1–ANGPT2 axis as a potential therapeutic target in IBD.

2025-12-31 | GSE314630 | GEO

Antioxidants rescue murine mesangial cells from docosahexaenoic acid-induced ferroptosis

Project description:Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have long been associated with health benefits, including anti-inflammatory effects, but only few studies investigated the effects on kidney health. Preclinical data from animal models suggest that n-3 PUFAs may reduce glomerulosclerosis, albuminuria and inflammation, but the molecular mechanisms remain elusive. In this study, we investigated the potential protective effects of docosahexaenoic acid (DHA) on murine mesangial cells. However, stimulation with DHA alone led to a substantial reduction in viability and ultimately to cell death. Proteomic profiling identified a significant upregulation of ferroptosis, including the increased abundance of the key pro-ferroptotic protein HMOX1 and simultaneous downregulation of the pro-ferroptotic proteincs TFRC and ACSL4. These finding indicate an imbalance of cellular pro- and anti-ferroptotic self-protection mechanisms in DHA-treated cells. On the contrary, treatment with Ferrostatin-1, a known ferroptosis inhibitor, preserved cellular metabolic activity and prevented cell death, strongly supporting a role of ferroptosis in DHA-induced cytotoxicity. Furthermore, co-treatment with DHA and an antioxidant cocktail also significantly attenuated DHA-induced cell death and induced upregulation of several key anti-ferroptotic proteins, including TXNRD1 and GPX4, while further downregulating pro-ferroptotic proteins such as TFRC and ASCL4. Our findings provide novel insights into the ferroptotic response induced by DHA in mesangial cells and highlight the potential of antioxidant co-treatment to counteract this effect. This underscores the importance of a balance between pro- and anti-ferroptotic mechanisms in therapeutic strategies using n-3 PUFAs to promote kidney health.

2026-01-12 | PXD065885 | Pride

Protein kinase A regulates ferroptosis by controlling GPX4 m6A modification through phosphorylation of ALKBH5

Project description:GPX4-dependent ferroptosis has emerged as a therapeutic strategy for cancer treatment. Here, we demonstrated that protein kinase A (PKA) participates in the regulation of ferroptosis by controlling the m6A modification of GPX4 in an ALKBH5-dependent manner. Notably, we identified ALKBH5, an m6A demethylase, as a novel target of PKA, which drives phosphorylation-dependent degradation of ALKBH5 protein. Moreover, the deletion of ALKBH5 represses ferroptotic cell death by maintaining GPX4 m6A modification and stability. Thus, by regulating ALKBH5-dependent GPX4 stability, PKA acts as a key regulator of ferroptosis. Our study unveils the involvement of PKA in m6A modification, which could control GPX4-dependent ferroptosis and tumor progression.

2025-12-09 | GSE283869 | GEO

Interactome of ferroptosis pathways genes

Project description:We conducted a proteomic interactome analysis of well-known regulators of ferroptosis, ACSL4, LPCAT3, ALOX12, ALOX15, PEBP1, NCOA4, GCH1, FSP1, DHODH, SLC7A11, GCLC, GCLM, GSS, and GPX4. Take LPCAT3 as an example, we uncovered an opposing role of its binding protein CEPT1 in suppressing ferroptosis.

2024-10-17 | PXD035146 | Pride

RNA-seq of human pancreatic cancer cell line PANC-1 treated with RSL-3, N6F11, Fin56 and Erastin against untreated controls

Project description:Ferroptotic cell death is dependent on unrestricted lipid peroxidation rather than activation of apoptotic effector caspases. A large number of ferroptosis activators have been reported recently. We used gene sequencing to analyze the effects of four ferroptosis activators (RSL3, N6F11, Fin56 and Erastin) on global gene expression in human PDAC1 cell line.

2023-10-18 | E-MTAB-12241 | biostudies-arrayexpress

Transcriptomic Profiling of L-Proline Induced Ferroptosis Reveals PPARγ-Mediated Regulatory Networks in HFpEF Progression

Project description:This study investigates the molecular mechanisms by which L-proline contributes to heart failure with preserved ejection fraction (HFpEF) through ferroptosis. L-proline was found to exacerbate ferroptotic stress in cardiac tissue, partly by modulating the expression of key antioxidant and lipid metabolism genes. Notably, L-proline suppressed PPARγ signaling, a critical regulator of ferroptosis resistance and metabolic homeostasis. Downregulation of PPARγ led to activation of pro-ferroptotic mediators, including ACSL4 and TFR1, suggesting a mechanistic link between amino acid metabolism and cardiac vulnerability in HFpEF.

2025-09-17 | GSE308324 | GEO

A genome-wide CRISPR screen identifies mediators of ferroptosis sensitivity in polyunsaturated fatty acid-treated cells

Project description:Polyunsaturated fatty acids (PUFA) sensitize cells to ferroptotic cell death. In the study associated with this dataset, we used UACC257 as a model cell line (intrinsically resistant to ferroptosis) induced to be sensitive to ferroptosis with different PUFAs. We performed genome-wide CRISPR knockout screen to identify genes that mediate the sensitivity to ML210, a selective inhibitor of glutathione peroxidase 4 (GPX4) and a potent inducer of ferroptotic cell death. We identified cytochrome P450 oxidoreductase (POR, CYPOR) as a key player required for ferroptotic cell death among other genes.

2020-01-01 | GSE130982 | GEO

Nrf2 ablation abolishes liver tumorigenesis by suppressing L-2-hydroxyglutarate-driven regulation of ferroptosis in a spontaneous liver tumor model induced by hepatic Tsc1 deletion

Project description:The metabolite L-2-hydroxyglutarate (L2HG) regulates liver tumor development through both anti- and pro-ferroptotic mechanisms, mediated via the Nrf2/Slc7a11 and Atf4/Chac1 signaling axes. To investigate the essential role of Nrf2 in L2HG-driven ferroptosis regulation, we analyzed gene expression profiles in liver tumors from Tsc1f/f wild-type, Tsc1f/fAlbCre+, and Tsc1f/fAlbCre+/Nrf2-/- mice. We found that the ferroptosis-related transcriptome in Tsc1f/fAlbCre+/Nrf2-/- mice more closely resembled that of tumor-free Tsc1f/f wild-type mice than the tumor-bearing Tsc1f/fAlbCre+ cohort. These findings demonstrate that Nrf2 ablation disrupts L2HG-induced cystine uptake via the xCT antiporter system, rewires metabolic pathways, and restores ferroptotic sensitivity. This metabolic reprogramming effectively suppresses liver tumor development in vivo, underscoring the critical oncogenic interplay between L2HG metabolism and Nrf2-mediated ferroptosis resistance.

2025-07-26 | GSE301997 | GEO

Cell density-dependent ferroptosis in breast cancer is induced by accumulation of polyunsaturated fatty acid-enriched triacylglycerides

Project description:Ferroptosis is a regulated form of necrotic cell death caused by iron-dependent phospholipid peroxidation. It can be induced by inhibiting glutathione peroxidase 4 (GPX4), the key enzyme for efficiently reducing peroxides within phospholipid bilayers. Recent data suggest that cancer cells undergoing EMT (dedifferentiation) and those resistant to standard therapy expose a high vulnerability toward ferroptosis. Although recent studies have begun to identify and characterize the metabolic and genetic determinants underlying ferroptosis, many mechanisms that dictate ferroptosis sensitivity remain unknown. Here, we show that low cell density sensitizes primary mammary epithelial and breast cancer cells to ferroptosis induced by GPX4 inhibition, whereas high cell density confers resistance. These effects occur irrespective of oncogenic signaling, cellular phenotype and expression of the fatty acid ligase acyl-CoA synthetase long chain family member 4 (ACSL4). By contrast, we show that a massive accumulation of neutral triacylglycerides (TAG) enriched with polyunsaturated fatty acids (PUFA) is induced at low cell density. In addition, de novo lipogenesis and desaturation pathways were found to be reduced at low cell density, indicative of increased fatty acid uptake. Our study suggests that PUFA-mediated toxicity is limited by the enrichment in TAGs that in turn might pose a vulnerability towards ferroptosis. Conclusively, cell density regulates lipid metabolism of breast epithelial and cancer cells, which results in a ferroptosis-sensitive cell state with the potential to be exploited therapeutically during metastatic dissemination.

2020-11-13 | PXD016276 | Pride

CRISPR activation screens identify the SWI-SNF ATPases as suppressors of ferroptosis [NGS4183_ATAC]

Project description:Ferroptosis is an iron-dependent cell death mechanism characterized by an accumulation of toxic lipid peroxides and membrane rupture. The glutathione dependent enzyme, GPX4 (glutathione peroxidase 4), prevents ferroptosis by reducing these lipid peroxides into non-toxic lipid alcohols. Ferroptosis induction by GPX4 inhibition has emerged as a vulnerability of cancer cells, thus highlighting the need to identify ferroptosis regulators that may be exploited therapeutically. Through genome-wide screens and a series of genetic, genomic, and quantitative imaging approaches, we identify the SWI-SNF ATPases BRM and BRG1 as ferroptosis suppressors. Mechanistically, they directly bind to and catalytically increase chromatin accessibility at NRF2 target loci, thus boosting NRF2 transcriptional output. This primes cells to counter lipid peroxidation and confers resistance to GPX4 inhibition and ferroptosis. Importantly, we demonstrate that the BRM/BRG1-ferroptosis connection can be leveraged to enhance the paralog dependency of BRG1-mutant lung cancer cells on BRM, especially in lines that are less sensitive to BRM inhibition or degradation. Our data reveal ferroptosis induction as a potential avenue for broadening the efficacy of BRM degraders/inhibitors and define a specific genetic context for exploiting GPX4 dependency.

2024-07-01 | GSE245248 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data